【券商聚焦】中信建投:理顺AI辅助诊断收费路径 有望加速AI在病理领域的广泛使用

金吾财讯
Dec 24, 2025

金吾财讯 | 中信建投发研报指,国家医保局发布《病理类医疗服务价格项目立项指南》,此次立项指南将“提供病理切片数字化图像”和“上传病理诊断报告”作为病理服务的应尽事项,并将“人工智能辅助诊断”列为病理诊断的扩展项,旨在推动数字化和人工智能在病理科的应用。同时,立项指南单设病理诊断价格项目,区分方法学,突出技术劳务价值,并单列病理样本检测价格项目,使得高通量测序等项目收费合规化,有望激励医疗机构规范、积极地开展NGS检测项目。检验价格立项指南也有望于近期发布,建议关注明年病理及检验各省收费调整情况。

该机构表示,理顺AI辅助诊断收费路径,有望加速AI在病理领域的广泛使用。此次立项指南明确将“人工智能辅助诊断”列为病理诊断的扩展项,并将人工智能辅助诊断纳入病理诊断价格项目的价格构成,指导各地在定价时关注人工智能辅助诊断的相关资源投入成本,在价格水平上进行整体调节和引导,为人工智能辅助诊断技术应用理顺收费路径,有望加速AI在病理领域的广泛使用。医疗机构可自行决定是否选用人工智能辅助诊断技术、自行决定选用哪家企业的产品,具体收益分配由医疗机构与企业自行协商确定。病理AI辅助诊断对临床效率的提升十分显著,以细胞病理为例,根据动脉网的数据,在诊断量最多的宫颈癌细胞筛查中,使用AI辅助诊断的效率可提升70%-90%,未来应用前景广阔。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10